NCT04404192: An ongoing trial by VistaGen Therapeutics, Inc.
This trial is completed, but has been granted a delay in reporting its results.
It must report results 1 day, 2 hours ago.
Full data
| Full entry on ClinicalTrials.gov | NCT04404192 |
|---|---|
| Title | A Phase 2a Double-blind, Placebo-controlled, Parallel Study of PH94B Nasal Spray in the Treatment of Adjustment Disorder With Anxiety |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Oct. 12, 2021 |
| Completion date | Dec. 14, 2022 |
| Required reporting date | Dec. 14, 2025, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |